# Safety and Efficacy in Patients Treated for Hip or Knee PJI With Vancomycin and Tobramycin Joint Irrigation

> **NCT03721328** · PHASE2 · COMPLETED · sponsor: **Osteal Therapeutics, Inc.** · enrollment: 15 (actual)

## Conditions studied

- Prosthetic Joint Infection

## Interventions

- **COMBINATION_PRODUCT:** vancomycin hydrochloride and tobramycin sulfate

## Key facts

- **NCT ID:** NCT03721328
- **Lead sponsor:** Osteal Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-26
- **Primary completion:** 2020-08-25
- **Final completion:** 2020-08-25
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2022-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03721328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03721328, "Safety and Efficacy in Patients Treated for Hip or Knee PJI With Vancomycin and Tobramycin Joint Irrigation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03721328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*